HWK-206

N/A

Report date: 2025/06/04 16:49:33

Base Information

Drug NameHWK-206

Drug Alias NameHWK-206

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linker

Mechanisms of ActionAnti-Seizure protein 6 homologDNA topoisomerase I inhibitors

TargetsSeizure protein 6 homologDNA topoisomerase I

Therapy Area/IndicationsSmall Cell Lung CarcinomaNeuroendocrine Tumors

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesWuxi Biologics Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesWhitehawk Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsSmall Cell Lung CarcinomaNeuroendocrine Tumors

Inactive IndicationsN/A

Other Information

ATC CodeN/A